Haemolysis and myocardial and neural injury after monopolar pulsed field ablation using a novel lattice-tip catheter to treat atrial fibrillation
Open Access
- 1 September 2025
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 27 (9)
Abstract
Aims: The aim of this study was to assess the risk of haemolysis and the extent of myocardial and neural injury after monopolar, monophasic pulsed field ablation (PFA) using a lattice-tip catheter in comparison to single-shot PF ablation platforms employing bipolar, biphasic waveforms. Methods and results: This prospective study included consecutive patients undergoing PFA for atrial fibrillation (AF) using the Affera™ mapping and ablation system (n = 40). Biomarkers for haemolysis (haptoglobin, lactate dehydrogenase, bilirubin), myocardial injury [high-sensitive troponin T, creatine kinase (CK), creatine kinase MB (CK-MB)], neurocardiac injury (S100), and renal function (creatinine) were assessed pre- and within 24 h post-ablation. A subgroup analysis of first-time pulmonary vein isolation-only procedures compared biomarker changes across Affera™, Farapulse™ (PFA-F), and PulseSelect™ (PFA-P). Post-procedural haemolysis occurred across all PFA platforms. The decrease in Δhaptoglobin was most pronounced in PFA-F [AfferaTM: (−) 13.8 ± 18.5 vs. PFA-P: (−) 36.8 ± 35.9 vs. PFA-F: (−) 60.7 ± 26.3 mg/dL, P = <0.001], without haemolysis-related complications. AfferaTM shows a trend towards a higher increase in myocardial injury markers (Δtroponin, 1537 [580] vs. 970 [1023] vs. 1051 [592] pg/mL, P = 0.180; ΔCK, 232 [168] vs. 153 [132] vs. 102 [144] U/L, P = 0.006; ΔCK-MB, 28.5 [15.3] vs. 14.6 [12.4] vs. 13.6 [10.5] U/L, P = 0.055, for Affera TM, PFA-P, and PFA-F, respectively). After ablation, S100 increased in PFA-P and PFA-F, but not in AfferaTM. Conclusion: Post-procedural haemolysis after PFA for AF treatment is common and occurs across all PFA platforms. Pulsed field ablation using AfferaTM results in more myocardial injury than bipolar PFA systems with no indication of neural damage.Keywords
This publication has 33 references indexed in Scilit:
- Primer on Pulsed Electrical Field AblationCirculation: Arrhythmia and Electrophysiology, 2021
- Emerging Technologies for Pulmonary Vein IsolationCirculation Research, 2020
- A Lattice-Tip Temperature-Controlled Radiofrequency Ablation CatheterJACC: Clinical Electrophysiology, 2020
- Preclinical Evaluation of Pulsed Field AblationCirculation: Arrhythmia and Electrophysiology, 2019
- Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillationScience Translational Medicine, 2019
- Intracardiac pulsed field ablation: Proof of feasibility in a chronic porcine modelHeart Rhythm, 2019
- The S100B story: from biomarker to active factor in neural injuryJournal of Neurochemistry, 2018
- Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablationCardiology Journal, 2014
- Difference in Humoral Biomarkers for Myocardial Injury and Inflammation in Radiofrequency Ablation versus CryoablationPacing and Clinical Electrophysiology, 2007
- Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: Approach to size of necrosisAmerican Heart Journal, 1998